Back

Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism

Gilsbach, B. K.; Ho, F. Y.; Riebenbauer, B.; Zhang, X.; Guaitoli, G.; Kortholt, A.; Gloeckner, C. J.

2023-07-31 biochemistry
10.1101/2023.07.31.549909 bioRxiv
Show abstract

The Parkinsons Disease (PD)-linked protein Leucine Rich Repeat Kinase 2 (LRRK2) consists of seven domains, including a kinase and a Roc G domain. Despite the availability of several high-resolution structures, the dynamic regulation of its unique intramolecular domain stack is nevertheless still not well understood. By in-depth biochemical analysis, assessing the Michaelis-Menten kinetics of the Roc G domain, we have confirmed that LRRK2 has, similar to other Roco protein family members, a KM value of LRRK2 that lays within the range of the physiological GTP concentrations within the cell. Furthermore, the R1441G PD variant located within a mutational hotspot in the Roc domain showed an increased catalytic efficiency. In contrast, the most common PD variant G2019S, located in the kinase domain, showed an increased KM and reduced catalytic efficiency, suggesting a negative feedback mechanism from the kinase domain to the G domain. Autophosphorylation of the G1+2 residue (T1343) in the Roc P-loop motif is critical for this phosphoregulation of both the KM as well as the kcat values of the Roc-catalyzed GTP hydrolysis, most likely by changing the monomer-dimer equilibrium. The LRRK2 T1343A variant has a similar increased kinase activity in cells compared to G2019S and the double mutant T1343A/G2019S has no further increased activity suggesting that T1343 is crucial for the negative feedback in the LRRK2 signaling cascade. Together our data reveal a novel intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism. Interestingly, PD mutants differently change the kinetics of the GTPase cycle, which might in part explain the difference in penetrance of these mutations in PD patients.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Biochemical Journal
91 papers in training set
Top 0.1%
31.4%
2
Journal of Biological Chemistry
690 papers in training set
Top 0.7%
9.9%
3
Life Science Alliance
285 papers in training set
Top 0.3%
5.6%
4
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
29 papers in training set
Top 0.1%
5.6%
50% of probability mass above
5
International Journal of Molecular Sciences
494 papers in training set
Top 1%
5.2%
6
Scientific Reports
3612 papers in training set
Top 29%
3.5%
7
eLife
5828 papers in training set
Top 33%
3.3%
8
Protein Science
246 papers in training set
Top 2%
1.7%
9
Archives of Biochemistry and Biophysics
15 papers in training set
Top 0.2%
1.5%
10
Journal of Molecular Biology
232 papers in training set
Top 2%
1.3%
11
Open Biology
106 papers in training set
Top 1.0%
1.1%
12
Journal of Cell Science
393 papers in training set
Top 3%
1.1%
13
Structure
193 papers in training set
Top 2%
1.1%
14
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 34%
1.1%
15
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 3%
1.1%
16
Biochemistry
148 papers in training set
Top 2%
1.0%
17
Journal of Biomolecular Structure and Dynamics
43 papers in training set
Top 0.9%
1.0%
18
PLOS ONE
5266 papers in training set
Top 57%
1.0%
19
The FEBS Journal
93 papers in training set
Top 1%
1.0%
20
Biochimie
25 papers in training set
Top 0.6%
1.0%
21
Communications Biology
993 papers in training set
Top 26%
1.0%
22
Cellular and Molecular Life Sciences
96 papers in training set
Top 2%
0.9%
23
Journal of Neurochemistry
53 papers in training set
Top 1%
0.9%
24
iScience
1154 papers in training set
Top 34%
0.9%
25
Molecular Pharmacology
17 papers in training set
Top 0.2%
0.9%
26
Frontiers in Molecular Biosciences
102 papers in training set
Top 3%
0.6%
27
FEBS Open Bio
31 papers in training set
Top 1%
0.6%
28
EMBO Reports
263 papers in training set
Top 8%
0.6%